Exact Mass: 508.4102
Exact Mass Matches: 508.4102
Found 321 metabolites which its exact mass value is equals to given mass value 508.4102,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Fasciculol C
Fasciculol C is found in mushrooms. Fasciculol C is a constituent of mushrooms Naematoloma fasciculare and Naematoloma sublateritum
2'-Apo-beta-carotenal
2-Apo-beta-carotenal is found in citrus. 2-Apo-beta-carotenal is a trace constituent of Citrus specie Trace constituent of Citrus subspecies 2-Apo-beta-carotenal is found in citrus.
DG(14:1(9Z)/14:1(9Z)/0:0)
DG(14:1(9Z)/14:1(9Z)/0:0) is a diglyceride, or a diacylglycerol (DAG). It is a glyceride consisting of two fatty acid chains covalently bonded to a glycerol molecule through ester linkages. Diacylglycerols can have many different combinations of fatty acids attached at both the C-1 and C-2 positions. DG(14:1(9Z)/14:1(9Z)/0:0), in particular, consists of two chains of myristoleic acid at the C-1 and C-2 positions. The myristoleic acid moieties are derived from milk fats. Mono- and diacylglycerols are common food additives used to blend together certain ingredients, such as oil and water, which would not otherwise blend well. Dacylglycerols are often found in bakery products, beverages, ice cream, chewing gum, shortening, whipped toppings, margarine, and confections. Synthesis of diacylglycerol begins with glycerol-3-phosphate, which is derived primarily from dihydroxyacetone phosphate, a product of glycolysis (usually in the cytoplasm of liver or adipose tissue cells). Glycerol-3-phosphate is first acylated with acyl-coenzyme A (acyl-CoA) to form lysophosphatidic acid, which is then acylated with another molecule of acyl-CoA to yield phosphatidic acid. Phosphatidic acid is then de-phosphorylated to form diacylglycerol.Diacylglycerols are precursors to triacylglycerols (triglyceride), which are formed by the addition of a third fatty acid to the diacylglycerol under the catalysis of diglyceride acyltransferase. Since diacylglycerols are synthesized via phosphatidic acid, they will usually contain a saturated fatty acid at the C-1 position on the glycerol moiety and an unsaturated fatty acid at the C-2 position.
DG(14:1n5/0:0/14:1n5)
DG(14:1n5/0:0/14:1n5) is a diglyceride, or a diacylglycerol (DAG). It is a glyceride consisting of two fatty acid chains covalently bonded to a glycerol molecule through ester linkages. Diacylglycerols can have many different combinations of fatty acids attached at the C-1 C-2, or C-3 positions. DG(14:1n5/0:0/14:1n5), in particular, consists of two chains of myristoleic acid at the C-1 and C-3 positions. The myristoleic acid moieties are derived from milk fats. Mono- and diacylglycerols are common food additives used to blend together certain ingredients, such as oil and water, which would not otherwise blend well. Dacylglycerols are often found in bakery products, beverages, ice cream, chewing gum, shortening, whipped toppings, margarine, and confections.
Synthesis of diacylglycerol begins with glycerol-3-phosphate, which is derived primarily from dihydroxyacetone phosphate, a product of glycolysis (usually in the cytoplasm of liver or adipose tissue cells). Glycerol-3-phosphate is first acylated with acyl-coenzyme A (acyl-CoA) to form lysophosphatidic acid, which is then acylated with another molecule of acyl-CoA to yield phosphatidic acid. Phosphatidic acid is then de-phosphorylated to form diacylglycerol.
Diacylglycerols are precursors to triacylglycerols (triglyceride), which are formed by the addition of a third fatty acid to the diacylglycerol under the catalysis of diglyceride acyltransferase. Since diacylglycerols are synthesized via phosphatidic acid, they will usually contain a saturated fatty acid at the C-1 position on the glycerol moiety and an unsaturated fatty acid at the C-3 position.
FAHFA(16:1(9Z)/5-O-16:0)
Branched fatty acid esters of hydroxy fatty acids (FAHFAs) are endogenous lipids found in adipose tissue and serum that correlate with insulin sensitivity and are reduced in insulin-resistant humans. Structurally, they are characterized by a branched ester linkage between a fatty acid and a hydroxy-fatty acid. Different positions of the branched ester on the hydroxy fatty acid results in different isomers. FAHFA(16:1(9Z)/5-O-16:0), in particular, is formed from the condensation of the carboxy group of palmitoleic acid with the hydroxy group of 5-hydroxyhexadecanoic acid. It is alternatively named 5-POHPA since it is the 5-hydroxy isomer of the POHPA (palmitoleic acid-hydroxypalmitic acid) family.
FAHFA(16:1(9Z)/7-O-16:0)
Branched fatty acid esters of hydroxy fatty acids (FAHFAs) are endogenous lipids found in adipose tissue and serum that correlate with insulin sensitivity and are reduced in insulin-resistant humans. Structurally, they are characterized by a branched ester linkage between a fatty acid and a hydroxy-fatty acid. Different positions of the branched ester on the hydroxy fatty acid results in different isomers. FAHFA(16:1(9Z)/7-O-16:0), in particular, is formed from the condensation of the carboxy group of palmitoleic acid with the hydroxy group of 7-hydroxyhexadecanoic acid. It is alternatively named 7-POHPA since it is the 7-hydroxy isomer of the POHPA (palmitoleic acid-hydroxypalmitic acid) family.
FAHFA(16:1(9Z)/8-O-16:0)
Branched fatty acid esters of hydroxy fatty acids (FAHFAs) are endogenous lipids found in adipose tissue and serum that correlate with insulin sensitivity and are reduced in insulin-resistant humans. Structurally, they are characterized by a branched ester linkage between a fatty acid and a hydroxy-fatty acid. Different positions of the branched ester on the hydroxy fatty acid results in different isomers. FAHFA(16:1(9Z)/8-O-16:0), in particular, is formed from the condensation of the carboxy group of palmitoleic acid with the hydroxy group of 8-hydroxyhexadecanoic acid. It is alternatively named 8-POHPA since it is the 8-hydroxy isomer of the POHPA (palmitoleic acid-hydroxypalmitic acid) family.
FAHFA(16:1(9Z)/9-O-16:0)
Branched fatty acid esters of hydroxy fatty acids (FAHFAs) are endogenous lipids found in adipose tissue and serum that correlate with insulin sensitivity and are reduced in insulin-resistant humans. Structurally, they are characterized by a branched ester linkage between a fatty acid and a hydroxy-fatty acid. Different positions of the branched ester on the hydroxy fatty acid results in different isomers. FAHFA(16:1(9Z)/9-O-16:0), in particular, is formed from the condensation of the carboxy group of palmitoleic acid with the hydroxy group of 9-hydroxyhexadecanoic acid. It is alternatively named 9-POHPA since it is the 9-hydroxy isomer of the POHPA (palmitoleic acid-hydroxypalmitic acid) family.
FAHFA(16:1(9Z)/10-O-16:0)
Branched fatty acid esters of hydroxy fatty acids (FAHFAs) are endogenous lipids found in adipose tissue and serum that correlate with insulin sensitivity and are reduced in insulin-resistant humans. Structurally, they are characterized by a branched ester linkage between a fatty acid and a hydroxy-fatty acid. Different positions of the branched ester on the hydroxy fatty acid results in different isomers. FAHFA(16:1(9Z)/10-O-16:0), in particular, is formed from the condensation of the carboxy group of palmitoleic acid with the hydroxy group of 10-hydroxyhexadecanoic acid. It is alternatively named 10-POHPA since it is the 10-hydroxy isomer of the POHPA (palmitoleic acid-hydroxypalmitic acid) family.
FAHFA(16:1(9Z)/11-O-16:0)
Branched fatty acid esters of hydroxy fatty acids (FAHFAs) are endogenous lipids found in adipose tissue and serum that correlate with insulin sensitivity and are reduced in insulin-resistant humans. Structurally, they are characterized by a branched ester linkage between a fatty acid and a hydroxy-fatty acid. Different positions of the branched ester on the hydroxy fatty acid results in different isomers. FAHFA(16:1(9Z)/11-O-16:0), in particular, is formed from the condensation of the carboxy group of palmitoleic acid with the hydroxy group of 11-hydroxyhexadecanoic acid. It is alternatively named 11-POHPA since it is the 11-hydroxy isomer of the POHPA (palmitoleic acid-hydroxypalmitic acid) family.
FAHFA(16:1(9Z)/12-O-16:0)
Branched fatty acid esters of hydroxy fatty acids (FAHFAs) are endogenous lipids found in adipose tissue and serum that correlate with insulin sensitivity and are reduced in insulin-resistant humans. Structurally, they are characterized by a branched ester linkage between a fatty acid and a hydroxy-fatty acid. Different positions of the branched ester on the hydroxy fatty acid results in different isomers. FAHFA(16:1(9Z)/12-O-16:0), in particular, is formed from the condensation of the carboxy group of palmitoleic acid with the hydroxy group of 12-hydroxyhexadecanoic acid. It is alternatively named 12-POHPA since it is the 12-hydroxy isomer of the POHPA (palmitoleic acid-hydroxypalmitic acid) family.
FAHFA(16:1(9Z)/13-O-16:0)
Branched fatty acid esters of hydroxy fatty acids (FAHFAs) are endogenous lipids found in adipose tissue and serum that correlate with insulin sensitivity and are reduced in insulin-resistant humans. Structurally, they are characterized by a branched ester linkage between a fatty acid and a hydroxy-fatty acid. Different positions of the branched ester on the hydroxy fatty acid results in different isomers. FAHFA(16:1(9Z)/13-O-16:0), in particular, is formed from the condensation of the carboxy group of palmitoleic acid with the hydroxy group of 13-hydroxyhexadecanoic acid. It is alternatively named 13-POHPA since it is the 13-hydroxy isomer of the POHPA (palmitoleic acid-hydroxypalmitic acid) family.
FAHFA(16:1(9Z)/6-O-16:0)
Branched fatty acid esters of hydroxy fatty acids (FAHFAs) are endogenous lipids found in adipose tissue and serum that correlate with insulin sensitivity and are reduced in insulin-resistant humans. Structurally, they are characterized by a branched ester linkage between a fatty acid and a hydroxy-fatty acid. Different positions of the branched ester on the hydroxy fatty acid results in different isomers. FAHFA(16:1(9Z)/6-O-16:0), in particular, is formed from the condensation of the carboxy group of palmitoleic acid with the hydroxy group of 6-hydroxyhexadecanoic acid. It is alternatively named 6-POHPA since it is the 6-hydroxy isomer of the POHPA (palmitoleic acid-hydroxypalmitic acid) family.
2,6,10,15,19,23-Hexamethyl-3,6:7,10:11,14:15,18-tetraepoxytetracosane-22-ene-2,19-diol
20-Hydroxy-3,6,9,12,15,18-hexaoxaicos-1-yl laurate
(3alpha,11alpha,12beta,20S,23E)-25-hydroperoxydammar-23-ene-3,11,12,20-tetrol|probosciderol G
24xi-methyl-5alpha-cholestane-3beta,5,6beta,22R,24-pentol 6-acetate
(3alpha,11alpha,12beta,20S,24R)-24-hydroperoxydammar-25-ene-3,11,12,20-tetrol|probosciderol F
(24S)-24-methylcholestan-1beta,3beta,5alpha,6beta,25-pentaol-25-monoacetate|(24S)-24-methylcholestane-1beta,3beta,5alpha,6beta,25-pentol 25-monoacetate|(24S)-24-methylcholestane-1beta,3beta,5alpha,6beta,25-pentol-25-monoacetate|(24S)-24-methylcholestane-1beta,3beta,5alpha,6beta,25xi-pentol-25-monoacetate|(24S)-ergostane-1beta,3beta,5alpha,6beta,25-pentaol 25-monoacetate
(1beta,3alpha,12beta,20S,23E)-25-hydroperoxydammar-23-ene-1,3,12,20-tetrol|probosciderol I
(3beta,6alpha,12beta,20S,24S,25?鈥?-form-20,24-Epoxydammarane-3,6,12,25,26-pentol
(1beta,3alpha,12beta,20S,24R)-24-hydroperoxydammar-25-ene-1,3,12,20-tetrol|probosciderol H
(24S)-methylcholestan-3beta,5alpha,6beta,12beta,25-pentaol-25-oacetate|24S-24-methyl cholestane-3beta,5alpha,6beta,12beta,25-pentaol-25-O-acetate
Taraxasteroltiglinsaeureester|Tigloyl-20(30)-Taraxasten-3-ol
(3beta,12beta,20S,23S,24S)-20,24-Epoxydammarane-3,12,23,25,28-pentol
23xi,24xi-cycloartan-3beta,6alpha,16beta,23,24,25-hexaol|cycloorbigenin C
20(S)-Dammar-23-ene-25-hydroperoxyl-3??,6??,12??,20-tetrol
4,4,10,13,14-pentamethyl-17-(1,5,6-trihydroxy-6-methylheptan-2-yl)-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthrene-2,3,12-triol
4,4,10,13,14-pentamethyl-17-(1,5,6-trihydroxy-6-methylheptan-2-yl)-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthrene-2,3,12-triol
4,4,10,13,14-pentamethyl-17-(1,5,6-trihydroxy-6-methylheptan-2-yl)-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthrene-2,3,12-triol_major
b-Apo-2'-carotinal
Fasciculol C
(4Z,8Z,12Z,16Z,20Z,24Z)-4,8,12,16,20,24-hexamethyl-28-oxononacosa-4,8,12,16,20,24-hexaenal
[3-carboxy-2-[(13E,16E)-tetracosa-13,16-dienoyl]oxypropyl]-trimethylazanium
[3-Carboxy-2-[13-(3-methyl-5-pentylfuran-2-yl)tridecanoyloxy]propyl]-trimethylazanium
[3-Carboxy-2-[11-(5-hexyl-3,4-dimethylfuran-2-yl)undecanoyloxy]propyl]-trimethylazanium
[3-Carboxy-2-[11-(5-heptyl-3-methylfuran-2-yl)undecanoyloxy]propyl]-trimethylazanium
[3-Carboxy-2-[12-(3,4-dimethyl-5-pentylfuran-2-yl)dodecanoyloxy]propyl]-trimethylazanium
20(R),22(xi),24(S)-dammar-25(26)-ene-3beta,6alpha,12beta,20,22,24-hexanol
A tetracyclic triterpenoid that is dammarane with an exocyclic double bond at C-25 and substituent hydroxy groups at positions 3, 6, 12, 20, 22 and 24 (the 3beta,6alpha,12beta,24S stereoisomer). It is isolated from the leaves of Panax ginseng and exhibits cytotoxicity in the human hepatoma cell line, HepG2.
[3-carboxy-2-[(18Z,21E)-tetracosa-18,21-dienoyl]oxypropyl]-trimethylazanium
[O-[1-O-[(11Z)-11-Octadecenyl]-L-glycero-3-phospho]choline]anion
1-O-[(9Z)-Octadec-9-enyl]-glycero-3-phosphocholine
2-[hydroxy-[(2R)-2-hydroxy-3-[(E)-octadec-1-enoxy]propoxy]phosphoryl]oxyethyl-trimethylazanium
[3-hydroxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] (Z)-tetradec-9-enoate
[1-hydroxy-3-[(13Z,16Z)-tetracosa-13,16-dienoxy]propan-2-yl] pentanoate
[1-hydroxy-3-[(11Z,14Z)-icosa-11,14-dienoxy]propan-2-yl] nonanoate
[1-[(15Z,18Z)-hexacosa-15,18-dienoxy]-3-hydroxypropan-2-yl] propanoate
[1-[(13Z,16Z)-docosa-13,16-dienoxy]-3-hydroxypropan-2-yl] heptanoate
(1-hydroxy-3-octoxypropan-2-yl) (11Z,14Z)-henicosa-11,14-dienoate
[1-[(11Z,14Z)-henicosa-11,14-dienoxy]-3-hydroxypropan-2-yl] octanoate
(1-hydroxy-3-nonoxypropan-2-yl) (11Z,14Z)-icosa-11,14-dienoate
(2-Acetamido-3-hydroxyoctadecyl) 2-(trimethylazaniumyl)ethyl phosphate
(1-decoxy-3-hydroxypropan-2-yl) (9Z,12Z)-nonadeca-9,12-dienoate
[1-hydroxy-3-[(Z)-tetradec-9-enoxy]propan-2-yl] (Z)-pentadec-9-enoate
(1-dodecoxy-3-hydroxypropan-2-yl) (9Z,12Z)-heptadeca-9,12-dienoate
[1-[(Z)-hexadec-9-enoxy]-3-hydroxypropan-2-yl] (Z)-tridec-9-enoate
[3-Hydroxy-2-(pentanoylamino)pentadecyl] 2-(trimethylazaniumyl)ethyl phosphate
[2-(Hexanoylamino)-3-hydroxytetradecyl] 2-(trimethylazaniumyl)ethyl phosphate
[1-hydroxy-3-[(9Z,12Z)-octadeca-9,12-dienoxy]propan-2-yl] undecanoate
[1-hydroxy-3-[(Z)-pentadec-9-enoxy]propan-2-yl] (Z)-tetradec-9-enoate
[3-Hydroxy-2-(propanoylamino)heptadecyl] 2-(trimethylazaniumyl)ethyl phosphate
[3-Hydroxy-2-(nonanoylamino)undecyl] 2-(trimethylazaniumyl)ethyl phosphate
(1-hydroxy-3-tridecoxypropan-2-yl) (9Z,12Z)-hexadeca-9,12-dienoate
[1-[(9Z,12Z)-heptadeca-9,12-dienoxy]-3-hydroxypropan-2-yl] dodecanoate
[1-[(9Z,12Z)-hexadeca-9,12-dienoxy]-3-hydroxypropan-2-yl] tridecanoate
[2-(Butanoylamino)-3-hydroxyhexadecyl] 2-(trimethylazaniumyl)ethyl phosphate
[3-Hydroxy-2-(octanoylamino)dodecyl] 2-(trimethylazaniumyl)ethyl phosphate
[3-Hydroxy-2-(undecanoylamino)nonyl] 2-(trimethylazaniumyl)ethyl phosphate
[1-hydroxy-3-[(Z)-tridec-9-enoxy]propan-2-yl] (Z)-hexadec-9-enoate
[1-hydroxy-3-[(9Z,12Z)-nonadeca-9,12-dienoxy]propan-2-yl] decanoate
(1-hydroxy-3-undecoxypropan-2-yl) (9Z,12Z)-octadeca-9,12-dienoate
[2-(Heptanoylamino)-3-hydroxytridecyl] 2-(trimethylazaniumyl)ethyl phosphate
[2-(Decanoylamino)-3-hydroxydecyl] 2-(trimethylazaniumyl)ethyl phosphate
[(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] (Z)-pentadec-9-enoate
[2-(Dodecanoylamino)-3-hydroxyoctyl] 2-(trimethylazaniumyl)ethyl phosphate
(1-hydroxy-3-nonanoyloxypropan-2-yl) (9Z,12Z)-nonadeca-9,12-dienoate
(1-hydroxy-3-undecanoyloxypropan-2-yl) (9Z,12Z)-heptadeca-9,12-dienoate
(1-dodecanoyloxy-3-hydroxypropan-2-yl) (9Z,12Z)-hexadeca-9,12-dienoate
(1-decanoyloxy-3-hydroxypropan-2-yl) (9Z,12Z)-octadeca-9,12-dienoate
[1-hydroxy-3-[(Z)-tridec-9-enoyl]oxypropan-2-yl] (Z)-pentadec-9-enoate
(1-butanoyloxy-3-hydroxypropan-2-yl) (13Z,16Z)-tetracosa-13,16-dienoate
(1-acetyloxy-3-hydroxypropan-2-yl) (15Z,18Z)-hexacosa-15,18-dienoate
(1-heptanoyloxy-3-hydroxypropan-2-yl) (11Z,14Z)-henicosa-11,14-dienoate
(1-hydroxy-3-octanoyloxypropan-2-yl) (11Z,14Z)-icosa-11,14-dienoate
(1-hexanoyloxy-3-hydroxypropan-2-yl) (13Z,16Z)-docosa-13,16-dienoate
2-[hydroxy-[2-hydroxy-3-[(Z)-octadec-9-enoxy]propoxy]phosphoryl]oxyethyl-trimethylazanium
[(2S)-3-hydroxy-2-undecanoyloxypropyl] (9E,12E)-heptadeca-9,12-dienoate
[(2S)-1-hydroxy-3-undecanoyloxypropan-2-yl] (9E,12E)-heptadeca-9,12-dienoate
[(2S)-2-decanoyloxy-3-hydroxypropyl] (9E,12E)-octadeca-9,12-dienoate
[(2S)-1-decanoyloxy-3-hydroxypropan-2-yl] (9E,12E)-octadeca-9,12-dienoate
[(2S)-3-hydroxy-2-[(E)-tetradec-9-enoyl]oxypropyl] (E)-tetradec-9-enoate
[1-carboxy-3-[2-hydroxy-3-[(7E,10E,13E,16E)-nonadeca-7,10,13,16-tetraenoyl]oxypropoxy]propyl]-trimethylazanium
(2-dodecanoyloxy-3-hydroxypropyl) (4E,7E)-hexadeca-4,7-dienoate
1,2-Dimyristoleoyl-sn-glycerol
A 1,2-diacyl-sn-glycerol in which the acyl groups at positions 1 and 2 are both myristoleoyl groups.
6beta-acetoxy-24-methylcholestan-3beta,5alpha,22R,24-tetrol
diacylglycerol 28:2
A diglyceride in which the two acyl groups contain a total of 28 carbons and 2 double bonds.
LSM(20:1)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
(3s,6r)-6-[(1r,3as,3bs,5r,5ar,7s,9ar,9bs,11r,11ar)-5,5a,7,11-tetrahydroxy-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthren-1-yl]-2,3-dimethylheptan-2-yl acetate
(1s,3ar,3br,5as,7r,9r,9ar,9bs,11r,11ar)-1-[(2s,4e)-6-hydroperoxy-2-hydroxy-6-methylhept-4-en-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthrene-7,9,11-triol
(1r,3as,7r,8r,9as,11s,11ar)-3a,6,6,9a,11a-pentamethyl-1-[(2r,5r)-1,5,6-trihydroxy-6-methylheptan-2-yl]-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthrene-7,8,11-triol
1-(5-hydroperoxy-2-hydroxy-6-methylhept-6-en-2-yl)-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthrene-7,10,11-triol
6-(2-{5,7-dihydroxy-2,2,5,7a-tetramethyl-hexahydroazuleno[5,6-b]oxiren-1a-yl}ethyl)-2,2,5a,7-tetramethyl-hexahydro-3h-1-benzoxepine-3,7-diol
3-{3-[5-hydroxy-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-7-(2-hydroxypropan-2-yl)-6,9a,9b-trimethyl-decahydrocyclopenta[a]naphthalen-6-yl}propanoic acid
(1s,3ar,3br,5as,7r,9r,9ar,9bs,11r,11ar)-1-[(2s,5r)-5-hydroperoxy-2-hydroxy-6-methylhept-6-en-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthrene-7,9,11-triol
3-[(3s,3ar,5ar,6s,7r,9ar,9br)-3-[(2s,5s)-5-hydroxy-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-7-(2-hydroxypropan-2-yl)-6,9a,9b-trimethyl-decahydrocyclopenta[a]naphthalen-6-yl]propanoic acid
20(s)-dammar-23-ene-25-hydroperoxyl-3β,6α,12β,20-tetrol
{"Ingredient_id": "HBIN003495","Ingredient_name": "20(s)-dammar-23-ene-25-hydroperoxyl-3\u03b2,6\u03b1,12\u03b2,20-tetrol","Alias": "NA","Ingredient_formula": "C30H52O6","Ingredient_Smile": "CC1(C(CCC2(C1C(CC3(C2CC(C4C3(CCC4C(C)(CC=CC(C)(C)OO)O)C)O)C)O)C)O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "4618","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
aglinin b
{"Ingredient_id": "HBIN014867","Ingredient_name": "aglinin b","Alias": "NA","Ingredient_formula": "C30H52O6","Ingredient_Smile": "CC12CCC(C1CCC3C2(CCC(C3(C)CCC(=O)O)C(C)(C)O)C)C4(CCC(O4)(C(C)(C)O)O)C","Ingredient_weight": "508.7 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "745","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "101035071","DrugBank_id": "NA"}
